Teva Pharmaceutical
TEVA
$0.20 (0.89%)
1D
1W
3M
1Y
5Y
ALL
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
The Motley Fool • 3 days ago • TEVA
Billionaire Stanley Druckenmiller Is Selling Nvidia and Palantir and Piling Into One of Wall Street's Hottest Drug Stocks Ahead of 2025GlobeNewsWire • 4 days ago • TEVA
Teva to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceBenzinga • 9 days ago • TEVA
Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related DiseasesZacks Investment Research • 9 days ago • TEVA
SNY, TEVA Stocks Jump on Encouraging Data From IBD Drug StudyCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.